Cargando…
The civil society monitoring of hepatitis C response related to the WHO 2030 elimination goals in 35 European countries
BACKGROUND: People who inject drugs (PWID) account for the majority of new cases of hepatitis C virus (HCV) infection in Europe; however, HCV testing, and treatment for PWID remain suboptimal. With the advent of direct acting antivirals (DAAs) the World Health Organization (WHO) adopted a strategy t...
Autores principales: | Maticic, M., Pirnat, Z., Leicht, A., Zimmermann, R., Windelinck, T., Jauffret-Roustide, M., Duffell, E., Tammi, T., Schatz, E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7678126/ https://www.ncbi.nlm.nih.gov/pubmed/33213481 http://dx.doi.org/10.1186/s12954-020-00439-3 |
Ejemplares similares
-
Hepatitis C elimination by 2030 in Malaysia: an achievable goal?
por: Mohamed, Rosmawati, et al.
Publicado: (2019) -
Harm reduction in Europe: a framework for civil society-led monitoring
por: Rigoni, Rafaela, et al.
Publicado: (2021) -
Eliminating viral hepatitis in children after liver transplants: How to reach the goal by 2030
por: Sintusek, Palittiya, et al.
Publicado: (2022) -
Hepatitis C virus: Current steps toward elimination in Germany and barriers to reaching the 2030 goal
por: Sarrazin, Christoph, et al.
Publicado: (2021) -
The global campaign to eliminate HBV and HCV infection: International Viral Hepatitis Elimination Meeting and core indicators for development towards the 2030 elimination goals
por: Popping, Stephanie, et al.
Publicado: (2019)